A number of families with X linked dilated cardiomyopathy with onset in infancy or childhood have now been described, with varying clinical and biochemical features. Of these, one condition, Barth syndrome (BTHS), can be diagnosed clinically by the characteristic associated features of skeletal myopathy, short stature, and neutropenia, but not all of these features are always present. Molecular genetic studies have delineated the gene for BTHS, which maps to distal Xq28, from the gene for so called X linked dilated cardiomyopathy (XLCM), a teenage onset dilated cardiomyopathy, recently mapped to the 5' portion of the dystrophin locus at Xp2l.
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We report a large family in which male infants have died with congenital dilated cardiomyopathy, and there is a strong family history of unexplained death in infant males over at least four generations. Death always occurred in early infancy, without development of the characteristic features associated with Barth syndrome. Molecular analysis localised the gene in this family to Xq28 with lod scores of 2-3 atO = 0 0 with dinucleotide repeat markers, p26 and p39, near DXS15 and at F8C. The proximal limit to the localisation of the gene in this family is defined by a recombinant at DXS296, while the distal limit could not be differentiated from the telomere. This localisation is consistent with a hypothesis of allelic and clinical heterogeneity at the BTHS locus in Xq28. ( Med Genet 1995; 32:383-388) The aetiology of familial cardiomyopathy, particularly those forms that are autosomally inherited, is heterogeneous, and cannot always be determined from the clinical or biochemical phenotype. Gene mapping of autosomal dominant hypertrophic cardiomyopathy (HCM) has implicated chromosomal regions 1 q3, 1 ipi 3- q13, 14ql 1, and 15q2, and a number of missense point mutations in the ,B cardiac myosin heavy chain gene on chromosome 14 Berko and Swift'2 reported a large kindred with X linked dilated cardiomyopathy (now designated XLCM) in which affected males presented with rapidly progressive dilated cardiomyopathy in their teens to early twenties, with much later onset and slower course in manifesting female carriers. This disorder is associated with raised muscle creatine kinase and abnormalities of cardiac muscle dystrophin, but with no skeletal muscle involvement. XLCM has recently been linked to the 5' portion ofthe dystrophin locus at Xp2 1.13 These two major loci of X linked cardiomyopathy, BTHS and XLCM, have only been clearly delineated by linkage analysis although they do show some clinical differences.
We report a large family with apparent X linked inheritance of a fatal infantile cardiomyopathy, in which we have regionally localised the gene responsible to Xq28. The clinical features in this family are insufficient to permit a definite diagnosis of Barth syndrome, and the cardiomyopathy is consistently of congenital onset and fatal in infancy. The possibility that this represents allelic heterogeneity within the BTHS locus is discussed with respect to these findings. 
V-3
The brother of V-1 was born at term, Apgar scores 6 and 8. He had occasional cyanosis from birth and fed poorly at times. Echocardiogram at 1 week and 3 weeks showed minimal left ventricular hypertrophy, but normal LV function. He died suddenly at 3-5 weeks; no necropsy was performed.
VS5
He was born at term, birth weight 3000 g, Apgar scores 3 and 9. He was lethargic and cyanosed from birth and had mild talipes equinovarus. Echocardiography showed marked biventricular hypertrophy with tricuspid regurgitation and a right to left shunt at the foramen ovale. He required assisted ventilation for several days but was able to be extubated by day 4. Investigations included electrolytes, urea, creatinine, calcium, urine metabolic screen, lactate, pyruvate, full blood count and differential, carnitines, plasma amino acids, and very long chain fatty acids. Total, free, and acylcarnitines were normal as was his neutrophil count. There was no evidence ofmethylglutaconic aciduria. He was maintained on antifailure treatment and stabilised for several months, but had suboptimal weight gain and gradually deteriorated and died at the age of 5 months.
Birth weight was 2700 g and Apgar scores 8 and 10. He fed poorly from birth but was first investigated at 6 weeks when he presented cyanosed and in cardiac failure; chest x ray showed cardiomegaly. He was clinically much improved after starting antifailure therapy, but the cardiomegaly persisted. He died at 5 months; no necropsy was performed, and no record of echocardiographic findings was available.
The available history for the following two infants was taken from medical records kept at the small country hospital where they were born. There is also a strong family history of unexplained death of infant males, all less than 6 months old, occurring over at least four generations, including III-6, III-9, III11, III 13, IV-2, IV-3, IV 9, and IV-16. Medical records for these and other possibly affected infants were either uninformative or not found.
DNA ANALYSIS
Genotyping of several dinucleotide repeat and RFLP markers in Xq27-28 was undertaken (table 1). The order of markers used was: cen-DXS548-DXS296(VK21A)-DXSI 1 13-GAB- Linkage analysis was performed using the computer programs MLINK for two point lod scores and LINKMAP for multipoint analysis. The analyses included all people from whom DNA samples were collected. The recombination fractions between loci included in the multipoint analysis were: DXS296-0 001-DXS 1113-0 10-DXS52-0-008-p26, p39, DX-S 15-0 001-DXS707-0*001-DXS605-0 001-F-8C-0 005-DXS1108. The disease gene frequency was set at 1/10 000 and analysis assumed X linked recessive inheritance. For diseases with an X linked mode of inheritance the critical value of the lod score is ZO>2-0 for demonstration of linkage.24
Results
Pairwise lod scores at 10 marker loci in Xq28 and at STR44 in Xp21 are given in table 2. The maximum lod score of 2-30 at a recombination frequency of 0-0 was generated at the p26 and p39 markers near DXS15 and at F8C. The STR50, DXS548, GABRA3, and DXYS154 loci were uninformative in this family. A recombination event was observed with DXS296 (VK21A) in subject III-8. Her status as a carrier is based on clinical records showing that her sons had a clinical presentation consistent with the suspected cause of death, congenital cardiomyopathy.
All of the people from whom DNA samples were collected were included in the analysis. The genotypes of III-3 and III-5, for example, consistent with localisation ofthe gene to Xq28, overlapping with the regional localisation for BTHS. The proximal limit to the gene localised in this family is defined by recombination at DXS296 in a single subject III-8, given the clinical evidence that her sons died of congenital cardiomyopathy. Since the parental genotypes in generation II are not available and could not be inferred at any ofthe markers used distal to DXS296, no further recombinations could be detected. The gene responsible for fatal infantile cardiomyopathy is located within an interval spanning 11 cM of Xq28 from DXS296 to qter. The BTHS locus has been mapped between DXS369 and qter"' and in the interval DXS374 to qter.11 The marker DXS369 is proximal to DXS548 and DXS296, while DXS374 is an RFLP proximal and close to GABRA3 and distal to DXS1 113. Co-localisation of both disorders could imply genetic homogeneity, with clinical heterogeneity explained by allelism at the same locus. Alternatively, it must be considered that there may be more than one gene for dilated cardiomyopathy in Xq28, which is a known gene rich area of the genome.
The two patients in family 2 of Orstavik et a18 died within four weeks of birth from heart failure presenting prenatally. These cases with congenital cardiomyopathy may represent examples of the same severe entity that we describe, which may be a congenital variant of BTHS.
Major features described in BTHS include mitochondrial structural changes suggestive of a disorder in mitochondrial energy metabolism. Nuclear encoded genes affecting mitochondrial function may be possible candidates for this disorder. Mitochondrial abnormalities are not always seen in Barth syndrome families" 101 and, if present, are non-specific so may be a secondary effect. Therefore genes for structural muscle proteins could equally well be candidates as genes involved in mitochondrial energy metabolism.
In the XLCM form, there is no weakness or histological evidence for skeletal muscle dystrophy although raised creatine kinase (CK) levels were reported."3 It is known that some Becker muscular dystrophy (BMD) patients, despite mild skeletal myopathy, may have severe cardiomyopathy. It is suggested that the cardiomyopathy in XLCM and in these BMD cases may arise through particular mutations in the dystrophin gene, or perhaps in dystrophin regulatory regions at Xp2 1.
Emery-Dreifuss muscular dystrophy (EDMD) mapped to distal Xq28 is a slowly progressive, later onset disorder of skeletal myopathy and contractures, and a cardiomyopathy usually presenting with prominent atrial involvement, heart block, and rhythm disturbances. 25 Candidate genes derived for EDMD should therefore also be examined in cardiomyopathy families linked to Xq28. The possibility exists that, in the same way that XLCM has been shown to be linked to the DMD/BMD region but without skeletal myopathy, Barth syndrome may be a specific mutation in the gene region causing cardiac defect in EDMD. 
